Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti‐CD20 × anti‐CD3), mediates efficient killing of B‐cell lymphoma cells even with very low CD20 expression levels-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti‐CD20 × anti‐CD3), mediates efficient killing of B‐cell lymphoma cells even with very low CD20 expression levels

Published:2008-09-01 Issue:5 Volume:123 Page:1181-1189
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Stanglmaier Michael,Faltin Margot,Ruf Peter,Bodenhausen Annette,Schröder Petra,Lindhofer Horst

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. Radiation Oncology Investigations 10657541 15206823 1999 7 6

2. Non‐Hodgkin's lymphoma;Greiner;Cancer,1995

3. Rituximab for the treatment of diffuse large B‐cell lymphomas;Held;Expert Rev Anticancer Ther,2006

4. Monoclonal antibody therapy for B‐cell malignancies;Cheson;Semin Oncol,2006

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid, site-specific labeling of “off-the-shelf” and native serum autoantibodies with T cell–redirecting domains;Science Advances;2022-05-06

2. Biology and Clinical Evaluation of T/NK Cell Engagers;Cancer Drug Discovery and Development;2022

3. T-cell engaging bispecific antibody therapy;Cancer Immunology and Immunotherapy;2022

4. Engineered Bifunctional Proteins for Targeted Cancer Therapy: Prospects and Challenges;Advanced Materials;2021-09-29

5. Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy;Cancers;2021-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP